特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959780

皮膚炎治療薬の世界市場 - COVID-19の影響と回復:2020年~2030年

Dermatitis Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
皮膚炎治療薬の世界市場 - COVID-19の影響と回復:2020年~2030年
出版日: 2020年09月09日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の皮膚炎治療薬市場について調査分析し、市場の特徴、市場規模と成長、市場セグメンテーション、地域別・国別の内訳、競合情勢、市場シェア、動向と戦略について、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 皮膚炎治療薬市場の特徴

第3章 皮膚炎治療薬市場規模と成長

  • 世界の皮膚炎治療薬市場実績 (金額)
    • 市場促進要因
    • 市場抑制要因
  • 世界の皮膚炎治療薬市場予測 (金額)
    • 市場促進要因
    • 市場抑制要因

第4章 皮膚炎治療薬市場セグメンテーション

  • 世界の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
    • コルチコステロイド
    • 皮膚軟化剤/保湿剤
    • 抗ヒスタミン剤
    • カルシニューリン阻害剤
    • 抗生物質
    • 免疫調節剤
    • インターロイキン阻害剤
  • 世界の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)
    • 病院
    • 小売薬局
    • ドラッグストア
    • オンライン/メール薬局
  • 世界の皮膚炎治療薬市場:投与経路別セグメンテーション、実績と予測 (金額)
    • 局所
    • 経口
    • 注射剤
  • 世界の皮膚炎治療薬市場:用途別セグメンテーション、実績と予測 (金額)
    • がん
    • 血液疾患
    • 慢性疾患
    • 感染症

第5章 皮膚炎治療薬市場の地域別・国別分析

  • 世界の皮膚炎治療薬市場:地域別、実績と予測 (金額)
  • 世界の皮膚炎治療薬市場:国別、実績と予測 (金額)

第6章 アジア太平洋の皮膚炎治療薬市場

  • アジア太平洋の皮膚炎治療薬市場概要
  • アジア太平洋の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • アジア太平洋の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第7章 中国の皮膚炎治療薬市場

  • 中国の皮膚炎治療薬市場概要
  • 中国の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 中国の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第8章 インドの皮膚炎治療薬市場

  • インドの皮膚炎治療薬市場概要
  • インドの皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • インドの皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第9章 日本の皮膚炎治療薬市場

  • 日本の皮膚炎治療薬市場概要
  • 日本の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 日本の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第10章 オーストラリアの皮膚炎治療薬市場

  • オーストラリアの皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • オーストラリアの皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第11章 インドネシアの皮膚炎治療薬市場

  • インドネシアの皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • インドネシアの皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第12章 韓国の皮膚炎治療薬市場

  • 韓国の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 韓国の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第13章 西欧の皮膚炎治療薬市場

  • 西欧の皮膚炎治療薬市場概要
  • 西欧の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 西欧の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第14章 英国の皮膚炎治療薬市場

  • 英国の皮膚炎治療薬市場概要
  • 英国の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 英国の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第15章 ドイツの皮膚炎治療薬市場

  • ドイツの皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • ドイツの皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第16章 フランスの皮膚炎治療薬市場

  • フランスの皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • フランスの皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第17章 東欧の皮膚炎治療薬市場

  • 東欧の皮膚炎治療薬市場概要
  • 東欧の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 東欧の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第18章 ロシアの皮膚炎治療薬市場

  • ロシアの皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • ロシアの皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第19章 北米の皮膚炎治療薬市場

  • 北米の皮膚炎治療薬市場概要
  • 北米の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 北米の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第20章 米国の皮膚炎治療薬市場

  • 米国の皮膚炎治療薬市場概要
  • 米国の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 米国の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第21章 南米の皮膚炎治療薬市場

  • 南米の皮膚炎治療薬市場概要
  • 南米の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 南米の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第22章 ブラジルの皮膚炎治療薬市場

  • ブラジルの皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • ブラジルの皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第23章 中東の皮膚炎治療薬市場

  • 中東の皮膚炎治療薬市場概要
  • 中東の皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • 中東の皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第24章 アフリカの皮膚炎治療薬市場

  • アフリカの皮膚炎治療薬市場概要
  • アフリカの皮膚炎治療薬市場:薬剤分類別セグメンテーション、実績と予測 (金額)
  • アフリカの皮膚炎治療薬市場:流通チャネル別セグメンテーション、実績と予測 (金額)

第25章 皮膚炎治療薬市場の競合情勢と企業プロファイル

  • 皮膚炎治療薬市場の競合情勢
  • 皮膚炎治療薬市場の企業プロファイル
    • LEO Pharma A/S
    • Novartis AG
    • Pfizer Inc.
    • Regeneron Pharmaceuticals Inc.
    • Sanofi S.A.

第26章 皮膚炎治療薬市場の主なM&A

第27章 皮膚炎治療薬市場の動向と戦略

第28章 製品パイプライン分析

第29章 皮膚炎治療薬市場の将来見通しと潜在的分析

第30章 付録

目次

Dermatitis Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global dermatitis drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the dermatitis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Dermatitis Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Drug Class: Corticosteroids; Emollients/Moisturizers; Antihistamines; Calcineurin Inhibitors; Antibiotics; Immunomodulators; Interleukin Inhibitors

2) By Distribution Channel: Hospital; Retail Pharmacies; Drug Stores; Online Or Mail Pharmacies

3) By Route Of Application: Topical; Oral; Injectable

4) By Application: Cancer; Blood Disorders; Chronic Diseases; Infectious Diseases

Companies Mentioned: LEO Pharma A/S; Novartis AG; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; Sanofi S.A.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Dermatitis Drugs Market Characteristics

3. Dermatitis Drugs Market Size And Growth

  • 3.1. Global Dermatitis Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Dermatitis Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Dermatitis Drugs Market Segmentation

  • 4.1. Global Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Corticosteroids
    • Emollients/Moisturizers
    • Antihistamines
    • Calcineurin Inhibitors
    • Antibiotics
    • Immunomodulators
    • Interleukin Inhibitors
  • 4.2. Global Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospital
    • Retail Pharmacies
    • Drug Stores
    • Online Or Mail Pharmacies
  • 4.3. Global Dermatitis Drugs Market, Segmentation By Route Of Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Topical
    • Oral
    • Injectable
  • 4.4. Global Dermatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Cancer
    • Blood Disorders
    • Chronic Diseases
    • Infectious Diseases

5. Dermatitis Drugs Market Regional And Country Analysis

  • 5.1. Global Dermatitis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Dermatitis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Dermatitis Drugs Market

  • 6.1. Asia-Pacific Dermatitis Drugs Market Overview
  • 6.2. Asia-Pacific Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Dermatitis Drugs Market

  • 7.1. China Dermatitis Drugs Market Overview
  • 7.2. China Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Dermatitis Drugs Market

  • 8.1. India Dermatitis Drugs Market Overview
  • 8.2. India Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Dermatitis Drugs Market

  • 9.1. Japan Dermatitis Drugs Market Overview
  • 9.2. Japan Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Dermatitis Drugs Market

  • 10.1. Australia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Dermatitis Drugs Market

  • 11.1. Indonesia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Dermatitis Drugs Market

  • 12.1. South Korea Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Dermatitis Drugs Market

  • 13.1. Western Europe Dermatitis Drugs Market Overview
  • 13.2. Western Europe Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Dermatitis Drugs Market

  • 14.1. UK Dermatitis Drugs Market Overview
  • 14.2. UK Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Dermatitis Drugs Market

  • 15.1. Germany Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Dermatitis Drugs Market

  • 16.4. France Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Dermatitis Drugs Market

  • 17.1. Eastern Europe Dermatitis Drugs Market Overview
  • 17.2. Eastern Europe Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Dermatitis Drugs Market

  • 18.1. Russia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Dermatitis Drugs Market

  • 19.1. North America Dermatitis Drugs Market Overview
  • 19.2. North America Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Dermatitis Drugs Market

  • 20.1. USA Dermatitis Drugs Market Overview
  • 20.2. USA Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Dermatitis Drugs Market

  • 21.1. South America Dermatitis Drugs Market Overview
  • 21.2. South America Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Dermatitis Drugs Market

  • 22.1. Brazil Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Dermatitis Drugs Market

  • 23.1. Middle East Dermatitis Drugs Market Overview
  • 23.2. Middle East Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Dermatitis Drugs Market

  • 24.1. Africa Dermatitis Drugs Market Overview
  • 24.2. Africa Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Dermatitis Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Dermatitis Drugs Market Competitive Landscape
  • 25.2. Dermatitis Drugs Market Company Profiles
    • 25.2.1. LEO Pharma A/S
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Novartis AG
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Pfizer Inc.
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Regeneron Pharmaceuticals Inc.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Sanofi S.A.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Dermatitis Drugs Market

27. Dermatitis Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Dermatitis Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.